BMY

Bristol-Myers Squibb Co

Oct 13 • 10:04AM ET

43.56

-0.40 -0.90 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: PFE JNJ MRK LLY ABBV GILD AMGN AZN NVS

| Held by: VTI SCHD VOO IVV SPY VTV XLV JEPI VYM COWZ

Index	S&P 500	P/E	17.58	EPS (ttm)	2.48	Insider Own	0.06%	Shs Outstand	2.04B	Perf Week	-3.49%
Market Cap	88.67B	Forward P/E	7.23	EPS next Y	6.03	Insider Trans	-4.10%	Shs Float	2.03B	Perf Month	-5.71%
Enterprise Value	126.04B	PEG	0.24	EPS next Q	1.61	Inst Own	82.16%	Short Float	1.29%	Perf Quarter	-6.17%
Income	5.05B	P/S	1.86	EPS this Y	461.33%	Inst Trans	0.65%	Short Ratio	1.92	Perf Half Y	-14.09%
Sales	47.70B	P/B	5.08	EPS next Y	-6.62%	ROA	5.33%	Short Interest	26.34M	Perf YTD	-22.98%
Book/sh	8.57	P/C	6.51	EPS next 5Y	71.94%	ROE	29.31%	52W High	63.33 -31.21%	Perf Year	-17.49%
Cash/sh	6.69	P/FCF	6.08	EPS past 3/5Y	- -	ROIC	7.96%	52W Low	42.96 1.40%	Perf 3Y	-37.98%
Dividend Est.	2.47 (5.68%)	EV/EBITDA	6.65	Sales past 3/5Y	1.36% 13.06%	Gross Margin	61.74%	Volatility	1.84% 2.42%	Perf 5Y	-24.55%
Dividend TTM	2.48 (5.69%)	EV/Sales	2.64	EPS Y/Y TTM	176.42%	Oper. Margin	26.11%	ATR (14)	1.08	Perf 10Y	-29.70%
Dividend Ex-Date	Oct 03, 2025	Quick Ratio	1.11	Sales Y/Y TTM	2.57%	Profit Margin	10.58%	RSI (14)	37.78	Recom	2.62
Dividend Gr. 3/5Y	6.38% 7.57%	Current Ratio	1.21	EPS Q/Q	-22.37%	SMA20	-3.09%	Beta	0.34	Target Price	52.35
Payout	-	Debt/Eq	2.92	Sales Q/Q	0.56%	SMA50	-5.71%	Rel Volume	0.68	Prev Close	43.96
Employees	34100	LT Debt/Eq	2.64	Earnings	Oct 30 BMO	SMA200	-14.76%	Avg Volume	13.70M	Price	43.56
IPO	Jul 05, 1929	Option/Short	Yes / Yes	EPS/Sales Surpr.	33.79% 7.21%	Trades		Volume	1,242,886	Change	-0.90%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-05-25	Downgrade	Daiwa Securities	Outperform → Neutral	$42
Apr-22-25	Initiated	Piper Sandler	Overweight
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$55
Dec-16-24	Upgrade	Jefferies	Hold → Buy	$70
Dec-10-24	Resumed	BofA Securities	Neutral	$63
Nov-15-24	Initiated	Wolfe Research	Peer Perform
Nov-13-24	Upgrade	Daiwa Securities	Neutral → Outperform
Nov-12-24	Upgrade	Leerink Partners	Market Perform → Outperform	$73
Oct-25-24	Downgrade	Citigroup	Buy → Neutral	$75 → $55
Oct-17-24	Initiated	Bernstein	Mkt Perform	$56
Jul-29-24	Downgrade	Barclays	Overweight → Equal Weight	$41
Mar-11-24	Downgrade	Societe Generale	Buy → Hold
Feb-06-24	Downgrade	Redburn Atlantic	Buy → Neutral	$77 → $54
Jan-03-24	Downgrade	BofA Securities	Buy → Neutral	$68 → $60
Nov-15-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$68 → $55
Nov-09-23	Initiated	Deutsche Bank	Hold	$55
Nov-02-23	Downgrade	Daiwa Securities	Outperform → Neutral	$68 → $54
Oct-27-23	Upgrade	HSBC Securities	Reduce → Hold	$55 → $53
Oct-27-23	Downgrade	William Blair	Outperform → Mkt Perform
Oct-27-23	Downgrade	BMO Capital Markets	Outperform → Market Perform	$60

Show Previous Ratings

Today 08:50AM	Will the Orbital Acquisition Strengthen BMY's Cell Therapy Portfolio? (Zacks)
06:59AM	Bristol Myers Squibb to Present Data at ESMO 2025 Showcasing Progress of Oncology Portfolio Across Diverse Tumor Types (Business Wire)
05:00AM	SystImmune to Receive Milestone Payment from Bristol Myers Squibb Under Iza-Bren Collaboration (PR Newswire)
Oct-11-25 09:48AM	Bristol Myers Squibb's Alzheimer's Drug, BMS-986446, Granted FDA Fast Track Status (Insider Monkey)
Oct-10-25 01:28PM	BMS expands CAR-T portfolio with $1.5bn Orbital buyout (Pharmaceutical Technology)
12:19PM	Loading…
12:19PM	Bristol Myers Squibb Buys Private Biotech for $1.5 Billion. The Deal Wave Keeps Going. (Barrons.com)
11:57AM	Will Keytruda Continue to Aid Merck's Top Line in Q3 Earnings? (Zacks)
09:00AM	Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:03AM	Bristols $1.5B Orbital buyout extends in vivo cell therapy deal streak (BioPharma Dive)
06:59AM	Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics (Business Wire)
06:45AM	Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Initiative Spotlighting the Power of Support and Connection (Business Wire)
Oct-08-25 10:56AM	Can BMYs Neuroscience Portfolio Help to Diversify Its Business? (Zacks)
09:40AM	Why Bristol Myers Squibb (BMY) is a Top Value Stock for the Long-Term (Zacks)
08:50AM	Here's What to Expect From Pfizer's Oncology Drugs in Q3 Earnings (Zacks)
Oct-07-25 05:45PM	Bristol Myers Squibb (BMY) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
11:33AM	Loading…
Oct-06-25 11:33AM	Biotech Stocks Are Up. The Sector Is Looking Better Than It Has in Years. (Barrons.com)
Oct-05-25 11:14PM	Investing Smart: Bristol-Myers Squibb (BMY) Among the Best Affordable Dividend Stocks (Insider Monkey)
Oct-03-25 05:33AM	Bristol-Myers Squibb, Takeda, Astex Join AI Consortium to Train OpenFold3 for Accelerated Drug Discovery (Insider Monkey)
Oct-02-25 11:15AM	Can Novo Nordisk's Restructuring Program Drive its Return to Growth? (Zacks)
09:53AM	Bristol Myers Alzheimer's Drug Earns FDA Fast Track (GuruFocus.com)
09:10AM	Can CYTK Clinch a Potential FDA Nod for Its Cardiovascular Drug? (Zacks)
05:30AM	Chinese healthcare, biotech firms flock to Hong Kong for IPOs (South China Morning Post)
02:33AM	Bristol-Myers Squibb (BMY) Reports Strong Multiple Myeloma Data (Insider Monkey)
Oct-01-25 08:20PM	Bristol-Myers Squibb Company (BMY) Begins Selling Its Psoriasis Medication Sotyktu Directly to Cash-Paying U.S. Customers (Insider Monkey) +5.17%
03:19PM	Trump Triggered a Rally in Drug Stocks. Why It Might Not Last. (Barrons.com)
12:21PM	Why Is Bristol-Myers Squibb (BMY) Stock Rocketing Higher Today (StockStory)
10:01AM	What TrumpRx Means For Controversial Plan To Lower U.S. Drug Prices (Investor's Business Daily)
06:59AM	Bristol Myers Squibbs Anti-MTBR-Tau-Targeting Antibody, BMS-986446, Granted Fast Track Designation by U.S. FDA for the Treatment of Alzheimers Disease (Business Wire)
05:31AM	Bristol Myers, Takeda to pool data for AI-based drug discovery (Reuters)
Sep-30-25 05:45PM	Bristol Myers Squibb (BMY) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
04:47PM	Loading…
04:47PM	Pfizer Stock Soars on Trumps New Drug Pricing Plan. Heres Why. (Barrons.com)
03:19PM	3 Pharma Stocks Getting an Intraday Trump Bump (Schaeffer's Research)
02:49PM	Bernstein Maintains a Hold on Bristol-Myers Squibb Company (BMY) (Insider Monkey)
02:04PM	Jim Cramer Says "I Think I Might Be Wrong in Bristol" (Insider Monkey)
12:48PM	Trump's Plan To Lower U.S. Drug Prices Faces Big Test (Investor's Business Daily)
11:47AM	Pfizer Stock Rises After WSJ Reports Company Will Cut Drug Costs (The Wall Street Journal)
10:34AM	Pfizer, Other Drug Stocks Jump on Reports of Trump Pricing Plan (Barrons.com)
10:18AM	Krystal Biotech's Heavy Reliance on Vyjuvek: Growth Driver or Risk Factor? (Zacks)
06:30AM	Genmab Strikes $8 Billion Deal for Cancer Treatment Maker Merus (The Daily Upside)
04:00AM	Bristol-Myers Squibb Company (BMY) to Capitalize on Cell Therapy Edge to Pursue CAR-T Treatment Opportunities (Insider Monkey)
02:01AM	Trump visa curbs push U.S. firms to consider shifting more work to India (Reuters)
Sep-29-25 01:30PM	How Bristol-Myers Squibb Company (BMY) Delivers Strong Yields Even in Tough Markets (Insider Monkey)
09:11AM	AbbVie to launch ovarian cancer drug in UK at US price (Reuters)
09:00AM	Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Sep-27-25 09:07PM	Why Bristol-Myers Squibb (BMY) Deserves a Spot in Passive Income Portfolios (Insider Monkey)
Sep-26-25 11:43AM	AstraZeneca to Offer Discounted Drugs As Trump Pressures Pharma Industry to Cut Prices (The Wall Street Journal)
09:40AM	MRK vs. BMY: Which Pharma Stock Is the Smarter Pick Now? (Zacks)
07:24AM	Trumps overnight demand for 100% tariffs on pharmaceuticals will be a meaningful commercial hit for U.S. consumers, top analyst says (Fortune)
07:09AM	These Stocks Are Moving the Most Today: Eli Lilly, Wayfair, Intel, Oracle, Concentrix, Costco, and More (Barrons.com)
04:41AM	Is pharmas IRA pricing battle running out of steam? (Pharma Voice)
03:17AM	Trump Plans New Tariff Push With 100% Rate on Patented Drugs (Bloomberg)
Sep-25-25 10:52PM	US, European pharma stocks steady after Trump's tariff move, Asia slips (Reuters)
12:11PM	BMS expands DTC offering with Sotyktu addition (Pharmaceutical Technology)
10:05AM	PGIM Jennison Health Sciences Fund Sold its Position in Bristol-Myers Squibb Co. (BMY) in Q2 (Insider Monkey)
06:59AM	Bristol Myers Squibb Builds on Eliquis (apixaban) Direct-to-Patient Program, Announces New BMS Patient Connect Platform Offering Sotyktu (deucravacitinib) (Business Wire)
Sep-24-25 05:45PM	Bristol Myers Squibb (BMY) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
11:06AM	REPL Stock Plunges 54% in 3 Months After FDA Rejects Skin Cancer Drug (Zacks)
09:43AM	BMY Reports Positive Data From a Late-Stage Multiple Myeloma Study (Zacks)
07:45AM	The Smartest Dividend Stock to Buy With $1,000 Right Now (Motley Fool)
06:35AM	Should You Forget Pfizer and Buy These Unstoppable Stocks Instead? (Motley Fool)
12:12AM	Analyst Report: Bristol-Myers Squibb Company (Morningstar Research)
Sep-23-25 07:02PM	Bristol-Myers Squibb Company (BMY) to Divest 60% China JV Amid Strategic Realignment (Insider Monkey)
07:41AM	Bristol Myers says next-gen blood cancer drug hits goal in key study (BioPharma Dive)
06:59AM	Bristol Myers Squibb Announces Phase 3 EXCALIBER-RRMM Study Evaluating Iberdomide in Combination with Standard Therapies Demonstrated a Significant Improvement in Minimal Residual Disease Negativity Rates in Relapsed or Refractory Multiple Myeloma (Business Wire)
03:26AM	1 Reason to Buy Bristol Myers Squibb Stock (Motley Fool)
Sep-22-25 08:01AM	MapLight lines up an IPO in bid to challenge Bristol Myers schizophrenia drug (BioPharma Dive)
Sep-21-25 08:01AM	How To Put $100 In Your Retirement Fund Each Month With Bristol-Myers Squibb Stock (Benzinga)
Sep-19-25 06:45PM	Bristol-Myers Squibb Company's (BMY) Dividend Track Record: A Must-Have for a Dividend Stock Portfolio (Insider Monkey)
03:42PM	US Weighs Trump-Branded Website to Help Shop for Cheaper Drugs (Bloomberg)
10:14AM	Can Bristol Myers Squibb's Restructuring Program Boost Earnings Growth? (Zacks)
06:59AM	Bristol Myers Squibb to Report Results for Third Quarter 2025 on October 30, 2025 (Business Wire)
Sep-18-25 06:59PM	Why Replimune Stock Plummeted by Almost 40% Today (Motley Fool)
05:45PM	Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know (Zacks)
09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
08:45AM	Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises (PR Newswire)
Sep-17-25 04:48PM	Top Stock Reports for Exxon Mobil, AMD & Caterpillar (Zacks)
08:30AM	Advancing Cancer Research Brings New Hope for Patients Worldwide (PR Newswire)
06:59AM	Bristol Myers Squibb Announces Dividend (Business Wire)
12:04AM	Bristol Myers to sell 60% stake in China joint venture (Reuters)
Sep-16-25 02:58PM	What Does Wall Street Think About Bristol-Myers Squibb (BMY)? (Insider Monkey)
09:27AM	Bristol-Myers Squibb Company (BMY)-BioNTech Lung Cancer Therapy Shows 76% Tumor Reduction (Insider Monkey)
07:30AM	These stock-market experts don't love AI. Here's what they do recommend. (MarketWatch)
06:59AM	Bristol Myers Squibb to Participate in the Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum (Business Wire)
05:57AM	3 Great High-Yield Dividend Stocks to Buy in September (Motley Fool)
Sep-15-25 06:55AM	How Bad Is This Sector's Health Scare? (The Wall Street Journal)
Sep-12-25 10:25AM	Pfizer's Late-Stage Pipeline Fuels Long-Term Growth Prospects (Zacks)
09:08AM	BMY-BioNTech Partnership: A Potential Catalyst for Long-Term Gains? (Zacks)
09:00AM	Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know (Zacks)
03:00AM	Pfizer Is Growing More Reliant on Vaccines as Controversies Swirl (Barrons.com)
12:03AM	3 Reasons to Sell BMY and 1 Stock to Buy Instead (StockStory)
Sep-11-25 01:01PM	Bristol Myers Squibb, BioNTech Announce Positive Interim Data from Phase 2 Trial of Pumitamig in Lung Cancer (Insider Monkey)
12:49PM	BMO Capital Maintains a Hold on Bristol-Myers Squibb Company (BMY) (Insider Monkey)
10:01AM	Prothena Down 40% Year to Date: What Lies Ahead for the Stock? (Zacks)
09:52AM	Bristol Myers Loses 19.2% in Six Months: Buy, Sell or Hold? (Zacks)
06:30AM	Chinas Multibillion-Dollar US Pharma Pipeline Draws Scrutiny in Washington (The Daily Upside)
Sep-10-25 05:20AM	Flputnam Lifts Stake in Bristol-Myers Squibb Company (BMY) by 52% (Insider Monkey)
Sep-09-25 05:45PM	Bristol Myers Squibb (BMY) Outperforms Broader Market: What You Need to Know (Zacks)
01:17PM	SMMT Stock Plummets 25% on Regional Data Differences in NSCLC Study (Zacks)
10:15AM	Idiopathic pulmonary fibrosis breakthroughs may lead to first drug approval in years (Clinical Trials Arena)
06:05AM	The Best Ultra-High-Yield Dividend Stock to Invest $1,000 in Right Now (Motley Fool)

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Gallman Cari	EVP, General Counsel	Oct 02 '25	Option Exercise	0.00	4,558	0	13,398	Oct 06 05:22 PM
Elkins David V	EVP, Chief Financial Officer	Sep 02 '25	Sale	47.33	56,000	2,650,480	167,379	Sep 03 06:46 PM
Short Bartie Wendy	EVP, Corporate Affairs	Sep 01 '25	Option Exercise	0.00	1,235	0	6,301	Sep 03 06:42 PM
Elkins David V	Officer	Sep 02 '25	Proposed Sale	47.30	56,000	2,648,800		Sep 02 11:16 AM
Gallman Cari	EVP, General Counsel	Aug 01 '25	Option Exercise	0.00	1,061	0	9,383	Aug 05 06:01 PM
Short Bartie Wendy	EVP, Corporate Affairs	Aug 02 '25	Option Exercise	0.00	738	0	5,444	Aug 05 05:58 PM
Short Bartie Wendy	EVP, Corporate Affairs	Aug 02 '25	Sale	44.23	378	16,719	5,066	Aug 05 05:58 PM
Short Bartie Wendy	EVP, Corporate Affairs	Jun 03 '25	Option Exercise	0.00	8,040	0	8,040	Jun 04 05:37 PM
Hickey Benjamin	President, RayzeBio Org.	May 09 '25	Sale	38.01	97	3,702	0	May 13 07:03 PM
Hirawat Samit	EVP,Chief Med.Offr.,Drug Dev.	Apr 25 '25	Buy	47.58	4,250	202,215	83,513	Apr 29 06:14 PM
Shanahan Karin	EVP, Glob. Prod. Dev. & Supply	Apr 01 '25	Option Exercise	0.00	3,306	0	15,489	Apr 03 05:15 PM
Plenge Robert M	EVP, Chief Research Officer	Mar 10 '25	Option Exercise	0.00	11,255	0	20,148	Mar 12 09:39 PM
Meyers Gregory Scott	EVP, Chief Digital & Tech Off.	Mar 10 '25	Option Exercise	0.00	23,150	0	26,937	Mar 12 09:37 PM
Shanahan Karin	EVP, Glob. Prod. Dev. & Supply	Mar 10 '25	Option Exercise	0.00	20,423	0	22,339	Mar 12 09:35 PM
Lenkowsky Adam	EVP, Chief Commercial Officer	Mar 10 '25	Option Exercise	0.00	16,684	0	20,017	Mar 12 09:34 PM
Poole Ahn Amanda	EVP, Chief People Officer	Mar 10 '25	Option Exercise	0.00	7,164	0	8,546	Mar 12 09:32 PM
LEUNG SANDRA	EVP, General Counsel	Mar 10 '25	Option Exercise	0.00	48,718	0	386,496	Mar 12 09:32 PM
Hoch Lynelle	President, Cell Therapy Org.	Mar 10 '25	Option Exercise	0.00	7,446	0	7,920	Mar 12 09:31 PM
Holzer Phil M	SVP and Controller	Mar 10 '25	Option Exercise	0.00	7,140	0	17,870	Mar 12 09:31 PM
Hirawat Samit	EVP,Chief Med.Offr.,Drug Dev.	Mar 10 '25	Option Exercise	0.00	44,098	0	99,040	Mar 12 09:30 PM
Gallman Cari	EVP, Corporate Affairs	Mar 10 '25	Option Exercise	0.00	7,588	0	11,626	Mar 12 09:29 PM
Elkins David V	EVP, Chief Financial Officer	Mar 10 '25	Option Exercise	0.00	69,517	0	252,608	Mar 12 09:28 PM
BOERNER CHRISTOPHER S.	Chief Executive Officer	Mar 10 '25	Option Exercise	0.00	60,034	0	152,898	Mar 12 09:27 PM
Hickey Benjamin	President, RayzeBio Org.	Mar 01 '25	Option Exercise	0.00	3,286	0	10,419	Mar 04 05:44 PM
BOERNER CHRISTOPHER S.	Chief Executive Officer	Feb 20 '25	Buy	55.05	2,000	110,096	104,626	Feb 21 07:09 PM
Hirawat Samit	EVP,Chief Med.Offr.,Drug Dev.	Feb 14 '25	Buy	54.84	1,823	100,000	63,932	Feb 19 07:19 PM
Hickey Benjamin	President, RayzeBio Org.	Feb 01 '25	Option Exercise	0.00	10,078	0	10,858	Feb 04 07:05 PM
Meyers Gregory Scott	EVP, Chief Digital & Tech Off.	Feb 01 '25	Option Exercise	0.00	2,543	0	7,829	Feb 04 07:04 PM
Holzer Phil M	SVP and Controller	Nov 04 '24	Sale	55.62	700	38,930	11,760	Nov 05 05:53 PM
BOERNER CHRISTOPHER S.	Chief Executive Officer	Nov 01 '24	Option Exercise	0.00	2,964	0	104,169	Nov 05 05:42 PM
Hirawat Samit	EVP,Chief Med.Offr.,Drug Dev.	Nov 01 '24	Buy	54.67	1,830	100,055	62,109	Nov 05 05:41 PM
Holzer Phil M	Officer	Nov 04 '24	Proposed Sale	55.62	700	38,930		Nov 04 11:20 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BMY

Bristol-Myers Squibb Co

Upgrade your FINVIZ experience